Authors:
ZIKOS P
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO C
BREGANTE S
BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Haematologica, 83(2), 1998, pp. 132-137
Authors:
ZIKOS P
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
BREGANTE S
BERISSO G
MORDINI N
INCAGLIATO M
FUGAZZA G
SESSAREGO M
BACIGALUPO A
Citation: P. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - FAVORABLE IMPACT OF CHRONIC GRAFT-VERSUS-HOST DISEASE ON SURVIVAL AND RELAPSE, Haematologica, 83(10), 1998, pp. 896-903
Authors:
BACIGALUPO A
VANLINT BM
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
ZIKOS P
LOMBARDI A
Citation: A. Bacigalupo et al., EARLY PREDICTORS OF TRANSPLANT-RELATED MORTALITY (TRM) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - BLOOD UREA NITROGEN AND BILIRUBIN, Experimental hematology, 26(8), 1998, pp. 368-368
Authors:
BACIGALUPO A
ZIKOS P
VANLINT MT
VALBONESI M
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BREGANTE S
BERISSO G
VITALE V
SESSAREGO M
MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Experimental hematology, 26(5), 1998, pp. 409-414
Authors:
MORETTI S
ZIKOS P
VANLINT MT
TEDONE E
OCCHINI D
GUALANDI F
LAMPARELLI T
MORDINI N
BERISSO G
BREGANTE S
BRUNO B
BACIGALUPO A
Citation: S. Moretti et al., FOSCARNET VS GANCICLOVIR FOR CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - A RANDOMIZED STUDY, Bone marrow transplantation, 22(2), 1998, pp. 175-180
Authors:
ZIKOS P
VANLINT MT
FRASSONI F
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINE VS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Bone marrow transplantation, 21, 1998, pp. 38-38
Authors:
ZIKOS PM
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
BREGANTE S
BERISSO G
MORDINI N
INCAGLIATO M
FUGAZZA G
SESSAREGO M
VITALE V
BARRA S
CORVO R
BACIGALUPO A
Citation: Pm. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FAVORABLE IMPACTOF CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) ON SURVIVAL AND RELAPSE, Bone marrow transplantation, 21, 1998, pp. 39-39
Authors:
BACIGALUPO A
ZIKOS P
VANLINT MT
VALBONESI M
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BREGANTE S
BERISSO G
VITALE V
SESSAREGO M
MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 40-40
Authors:
BACIGALUPO A
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
LOMBARDI A
ZIKOS P
Citation: A. Bacigalupo et al., UNMANIPULATED TRANSPLANTS FROM 1-2-ANTIGEN MISMATCHED FAMILY DONORS, Bone marrow transplantation, 21, 1998, pp. 121-121
Authors:
BACIGALUPO A
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
LOMBARDI A
ZIKOS P
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE (THIO-CY) AS CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - REDUCING THE DOSE FOR PATIENTS AGED 45 TO 60 YEARS, Bone marrow transplantation, 21, 1998, pp. 357-357
Authors:
ZIKOS P
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Bone marrow transplantation, 21, 1998, pp. 490-490
Authors:
ZIKOS P
VANLINT MT
FRASSONI F
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
DESTEFANO F
SORACCO M
VITALE V
BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINEVERSUS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Blood, 91(9), 1998, pp. 3503-3508
Authors:
BACIGALUPO A
SORACCO M
VASSALLO F
ABATE M
VANLINT MT
GUALANDI F
LAMPARELLI T
OCCHINI D
MORDINI N
BREGANTE S
FIGARI O
BENVENUTO F
SESSAREGO M
FUGAZZA G
CARLIER P
VALBONESI M
Citation: A. Bacigalupo et al., DONOR LYMPHOCYTE INFUSIONS (DLI) IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(9), 1997, pp. 927-932
Authors:
PODESTA M
PIAGGIO G
FRASSONI F
PITTO A
MORDINI N
BREGANTE S
VALERIANI A
BACIGALUPO A
Citation: M. Podesta et al., DEFICIENT RECONSTITUTION OF EARLY PROGENITORS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(10), 1997, pp. 1011-1017
Authors:
BACIGALUPO A
MORDINI N
PITTO A
PIAGGIO G
PODESTA M
BENVENUTO F
VANLINT MT
VALBONESI M
LERCARI G
CARLIER P
LAMPARELLI T
GUALANDI F
OCCHINI D
BREGANTE S
FIGARI O
SORACCO M
VASSALLO F
DESTEFANO G
Citation: A. Bacigalupo et al., TRANSPLANTATION OF HLA-MISMATCHED CD34(- SEVERE IMMUNODEFICIENCY AND RELATED COMPLICATIONS() SELECTED CELLS IN PATIENTS WITH ADVANCED MALIGNANCIES ), British Journal of Haematology, 98(3), 1997, pp. 760-766
Authors:
MIKHAILOVA N
SESSAREGO M
FUGAZZA G
CAIMO A
DEFILIPPI S
VANLINT MT
BREGANTE S
VALERIANI A
MORDINI N
LAMPARELLI T
GUALANDI F
OCCHINI D
BACIGALUPO A
Citation: N. Mikhailova et al., CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA, Haematologica, 81(5), 1996, pp. 418-422
Authors:
BACIGALUPO A
BREGANTE S
TEDONE E
ISAZA A
VANLINT MT
MORO F
TRESPI G
OCCHINI D
GUALANDI F
LAMPARELLI T
MARMONT AM
Citation: A. Bacigalupo et al., COMBINED FOSCARNET-GANCICLOVIR TREATMENT FOR CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT), Bone marrow transplantation, 18, 1996, pp. 110-114
Authors:
BACIGALUPO A
BREGANTE S
TEDONE E
ISAZA A
VANLINT MT
TRESPI G
OCCHINI D
GUALANDI F
LAMPARELLI T
MARMONT AM
Citation: A. Bacigalupo et al., COMBINED FOSCARNET-GANCICLOVIR TREATMENT FOR CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Transplantation, 62(3), 1996, pp. 376-380
Authors:
BACIGALUPO A
VANLINT MT
VALBONESI M
LERCARI G
CARLIER P
LAMPARELLI T
GUALANDI F
OCCHINI D
BREGANTE S
VALERIANI A
PIAGGIO G
PITTO A
BENVENUTO F
FIGARI O
DESTEFANO G
CAIMO A
SESSAREGO M
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE FOLLOWED BY GRANULOCYTE-COLONY-STIMULATING FACTOR MOBILIZED ALLOGENEIC PERIPHERAL-BLOOD CELLS IN ADULTS WITH ADVANCED LEUKEMIA, Blood, 88(1), 1996, pp. 353-357
Authors:
BACIGALUPO A
VANLINT MT
VALBONESI F
LERCARI G
CARLIER P
LAMPARELLI T
GUALANDI F
OCCHINI D
BREGANTE S
VALERIANI A
PIAGGIO G
PITTO A
BENVENUTO F
FIGARI O
DESTEFANO G
CAIMO A
SESSAREGO M
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE FOLLOWED BY PERIPHERAL-BLOOD CELLS FROM HLAIDENTICAL SIBLINGS IN ELDERLY PATIENTS WITH ADVANCED LEUKEMIA, Blood, 86(10), 1995, pp. 377-377